*🔎 “What if your annual health check could see the cancers no one else checks for?”
That’s the idea behind CancerGuard™ — the first multi-cancer early detection blood test that casts a wider net than traditional screening.
🧬 What It Actually Checks
CancerGuard isn’t one cancer test — it’s a 50+ cancer signal detector from a single blood draw.
Think of it as a broad-spectrum radar for unusual DNA/protein signals that cancers shed into the bloodstream.
Here’s the real deal:
🎯 Lung & bronchus cancers
🎯 Pancreatic cancer
🎯 Liver & bile duct cancers
🎯 Stomach & esophageal cancers
🎯 Ovarian cancer
🎯 Kidney & bladder cancers
🎯 Head & neck cancers…and more.
It may detect signals for breast or prostate cancer, but it’s not meant to replace standard screening for those.
📊 Here’s what the science says:
• Detects signals in ~64 % of cancers in development studies
• ~97 % specificity — so false positives are low
• Finds ~1/3 of cancers early (Stage I/II) when outcomes are better
• Models suggest combined with guideline screening, this could mean fewer late-stage diagnoses and fewer deaths over time
📅 How It Fits With Your Screening
The CDC still recommends screenings:
✔ Mammograms (or other screening modality of choice)
✔ Colonoscopy/Cologuard or annual FIT tests
✔ Pap/HPV testing
✔ Lung CT if you qualify
Those tests catch cancers where we have proven recommendations.
CancerGuard is additional insight — especially for cancers that don’t yet have routine screening tools.
Who it’s for:
• Adults 50–84
• No active cancer diagnosis in the last 3 years
• Want more early detection insight
🧠 What a Result Means: this is a little tricky...
🟥 Positive signal: Something unusual showed up — not a diagnosis by itself. It means we need targeted follow-up with imaging or specialist evaluation.
🟩 Negative: Lowers likelihood, but doesn’t guarantee no cancer. You still keep up with guideline screenings.
💡 Giving it to you straight....
CancerGuard gives you a broader view than traditional screening — almost like moving from a flashlight to a radar sweep. It’s not perfect, and it’s not a replacement, but it’s the biggest leap in early detection coverage we’ve had in decades and affordable in comparison to previous available metrics.
Would you want this test?